20
Views
7
CrossRef citations to date
0
Altmetric
Perspective

Over-the-counter access to oral contraceptives

Pages 501-508 | Published online: 10 Jan 2014

References

  • Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect. Sex Reprod. Health38(2), 90–96 (2006).
  • Frost JJ, Singh S, Finer LB. U.S. women’s one-year contraceptive use patterns, 2004. Perspect. Sex Reprod. Health39(1), 48–55 (2007).
  • Smith JD, Oakley D. Why do women miss oral contraceptive pills? An analysis of women’s self-described reasons for missed pills. J. Midwifery Womens Health50(5), 380–385 (2005).
  • Grossman D. Should the contraceptive pill be available without prescription? Yes. BMJ337, a3044 (2008).
  • Centers for Disease Control and Prevention. U.S. medical eligibility criteria for contraceptive use. Morbid. Mortal. Weekly Rep.59 (2010).
  • Grossman D, Fernandez L, Hopkins K, Amastae J, Garcia SG, Potter JE. Accuracy of self-screening for contraindications to combined oral contraceptive use. Obstet. Gynecol.112(3), 572–578 (2008).
  • Grossman D, White K, Hopkins K, Amastae J, Shedlin M, Potter JE. Contraindications to combined oral contraceptives among over-the-counter compared with prescription users. Obstet. Gynecol.117(3), 558–565 (2011).
  • Yeatman SE, Potter JE, Grossman DA. Over-the-counter access, changing WHO guidelines, and contraindicated oral contraceptive use in Mexico. Stud. Fam. Plann.37(3), 197–204 (2006).
  • Zavala AS, Perez-Gonzales M, Miller P, Welsh M, Wilkens LR, Potts M. Reproductive risks in a community-based distribution program of oral contraceptives, Matamoros, Mexico. Stud. Fam. Plann.18(5), 284–290 (1987).
  • Shotorbani S, Miller L, Blough DK, Gardner J. Agreement between women’s and providers’ assessment of hormonal contraceptive risk factors. Contraception73(5), 501–506 (2006).
  • Becker D, Garcia SG, Ellertson C. Do Mexico city pharmacy workers screen women for health risks when they sell oral contraceptive pills over-the-counter? Contraception69(4), 295–299 (2004).
  • Tatum C, Garcia SG, Goldman L, Becker D. Valuable safeguard or unnecessary burden? Characterization of physician consultations for oral contraceptive use in Mexico city. Contraception71(3), 208–213 (2005).
  • Khader YS, Rice J, John L, Abueita O. Oral contraceptive use and the risk of myocardial infarction: a meta-analysis. Contraception68, 11–17 (2003).
  • Gillum L, Mamidipudi S, Johnston S. Ischaemic stroke risk with oral contraceptives: a meta-analysis. JAMA284, 72–78 (2000).
  • Trussell J. Contraceptive failure in the United States. Contraception83(5), 397–404 (2011).
  • Foster DG, Parvataneni R, de Bocanegra HT, Lewis C, Bradsberry M, Darney P. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet. Gynecol.108(5), 1107–1114 (2006).
  • Foster DG, Hulett D, Bradsberry M, Darney P, Policar M. Number of oral contraceptive pill packages dispensed and subsequent unintended pregnancies. Obstet. Gynecol.117(3), 566–572 (2011).
  • Shah MA, Shah NM, Al-Rahmani E, Behbehani J, Radovanovic Z. Over-the-counter use of oral contraceptives in Kuwait. Int. J. Gynaecol. Obstet.73(3), 243–251 (2001).
  • Potter JE, White K, Hopkins K, Amastae J, Grossman D. Clinic versus over-the-counter access to oral contraception: choices women make along the US–Mexico border. Am. J. Pub. Health100(6), 1130–1136 (2010).
  • Potter JE, McKinnon S, Hopkins K et al. Continuation of prescribed compared with over-the-counter oral contraceptives. Obstet. Gynecol.117(3), 551–557 (2011).
  • Landau SC, Tapias MP, McGhee BT. Birth control within reach: a national survey on women’s attitudes toward and interest in pharmacy access to hormonal contraception. Contraception74(6), 463–470 (2006).
  • Grossman D, Fernandez L, Hopkins K, Amastae J, Potter JE. Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas. Contraception81(3), 254–260 (2010).
  • McIntosh J, Rafie S, Wasik M et al. Changing oral contraceptives from prescription to over-the-counter status: an opinion statement of the women’s health practice and research network of the american college of clinical pharmacy. Pharmacotherapy31(4), 424–437 (2011).
  • Gardner JS, Miller L, Downing DF, Le S, Blough D, Shotorbani S. Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study. J. Am. Pharm. Assoc.48(2), 212–221 (2008).
  • Cackovic M, Paidas MJ. Should oral contraceptives be sold over-the-counter? No. Contemp. Ob. Gyn.53(9), 63–73 (2008).
  • Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence. JAMA285(17), 2232–2239 (2001).
  • Henderson JT, Sawaya GF, Blum M, Stratton L, Harper CC. Pelvic examinations and access to oral hormonal contraception. Obstet. Gynecol.116(6), 1257–1264 (2010).
  • American college of obstetricians and gynecologists. ACOG Practice Bulletin No. 109: cervical cytology screening. Obstet. Gynecol.114(6), 1409–1420 (2009).
  • Jarvis S. Should the contraceptive pill be available without prescription? BMJ337, a3056 (2008).
  • Harper CC, Brown BA, Foster-Rosales A, Raine TR. Hormonal contraceptive method choice among young, low-income women. How important is the provider? Patient Educ. Couns.81, 349–354 (2010).
  • Landau S, Besinque K, Chung F et al. Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States. J. Am. Pharm. Assoc.49(1), 43–50 (2009).
  • Liang SY, Grossman D, Phillips K. Women’s current out-of-pocket expenditures and dispensing patterns for oral contraceptives. Contraception83(6), 528–536 (2011).
  • Sullivan PW. Switching prescription drugs to over the counter: consumers may benefit financially in examples from the US. BMJ330(7496), 904–905 (2005).
  • Gianfrancesco F, Manning B, Wang R. Effects of prescription to OTC switches on out-of-pocket health care costs and utilization. Drug Benefit Trends14, 13–30, 44 (2002).
  • Black TR. Oral contraceptive prescription requirements and commercial availability in 45 developing countries. Stud. Fam. Plann.5(8), 250–254 (1974).
  • Bailey J, Jimenez RA, Warren CW. Effect of supply source on oral contraceptive use in Mexico. Stud. Fam. Plann.13(11), 343–349 (1982).
  • Ratanajamit C, Chongsuvivatwong V. Survey of knowledge and practice on oral contraceptive and emergency contraceptive pills of drugstore personnel in Hat Yai, Thailand. Pharmacoepidemiol. Drug Saf.10(2), 149–156 (2001).
  • Chin-Quee DS, Cuthbertson C, Janowitz B. Over-the-counter pill provision: evidence from Jamaica. Stud. Fam. Plann.37(2), 99–110 (2006).
  • Davidson LA, Pettis CT, Joiner AJ, Cook DM, Klugman CM. Religion and conscientious objection: a survey of pharmacists’ willingness to dispense medications. Soc. Sci. Med.71(1), 161–165 (2010).
  • Grimes DA, Lopez LM, O’Brien PA, Raymond EG. Progestin-only pills for contraception. Cochrane Database Syst. Rev.1, CD007541 (2010).
  • Cleland K, Peipert JF, Westhoff C, Spear S, Trussell J. Family planning as a cost-saving preventive health service. N. Engl. J. Med.364(18), e37 (2011).
  • Wazaify M, Shields E, Hughes CM, McElnay JC. Societal perspectives on over-the-counter (OTC) medicines. Fam. Pract.22, 170–176 (2005).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.